at the University of Pécs and at the University of Debrecen
Identification number: TÁMOP-4.1.2-08/1/A-2009-0011
CLINICAL TRIALS (3)
Dr. Judit Pongrácz
Three dimensional tissue cultures and tissue engineering – Lecture 25
Medical Biotechnology Master’s Programmes
at the University of Pécs and at the University of Debrecen
Identification number: TÁMOP-4.1.2-08/1/A-2009-0011
Tissue engineered blood vessel
• TE blood vessels are used only in low pressure pulmonary circulation
• These grafts are not durable enough to withstand high arterial pressure
Small-vein harvest
Cell seeding on polymer Cell isolation
Cell expansion
Tissue-engineered graft
TEBV production
• A completely biological tissue-engineered human blood vessel (Nicolas L'heureux, Stéphanie Pâquet, Raymond Labbé, Lucie Germain, and François A.
Auger ) FASEB Journal 1998
• HUVEC and SMC were used
Myocardial infaction
• Stem cells are used in cases following extensive damage
• In most cases improvement is shown but further studies are needed
Urethra and bladder
• Acellular collagen-based matrices
• Intestinal or bladder epithelial cells
• 4-7 years later 34 out of 40 patients had a successful outcome
Cartilage
• Two multicentre clinical trials
• In most cases improvement was noted
• Long term effects are still being considered
Lung
Trachea - bronchi - lungs
Lung diseases benefiting from cell based therapies
• COPD (chronic obstuctive pulmonary disease)
• ARDS (acute respiratory distress syndrome)
• Asthma
• Mechanical tissue damages
the lung
Pulmonary epithelial-like cells Embryonic stem cells
Culture Selection
(genetic, air liquid interface, media co-culture)
Epithelium Vasculature
Stroma (fibroblast)
ESCs, MSCs, Fibrocytes
Acute cytoprotection/repair (survival, growth factors)
Cartilage Intratracheal/Vascular infusion
Structural grafts
Engraftment Gene transfer
Delivery of therapeutic molecules Engraftment Organoid
Functional unit Endothelium
Pulmonary epithelium
Mesenchyme
Complexity of lung structures during development
Columnar cells
Fibroblasts
Goblet cell
Basal cell
Ciliated cell Clara cell Type I cell
Type II cell
I.
Embryonic E 9-12
II.
Pseudoglandular E 12-15
III.
Canalicular E 15-E17
IV.
Saccular E 17-Birth
V.
Alveolar Birth-PN20
Lung bud
Es Es
T T
RESEARCH
APPLICATION AND DRUG TESTING
Dr. Judit Pongrácz
Three dimensional tissue cultures and tissue engineering – Lecture 26
at the University of Pécs and at the University of Debrecen
Identification number: TÁMOP-4.1.2-08/1/A-2009-0011
Research applications
• Intercellular interaction
• Study of Signaling pathway (inter and intra-cellular)
• Study of regeneration processes
• Modeling diseases
Thymus reaggregation
E15 mouse embryo
T-lymphocytes or lymphoid progenitors
Deoxiguanosine cultures
Thymic epithelial cells E15 thymic lobes
Reaggregate
Thymocyte development in the reaggregated thymus
Intracellular Notch (ICN)
• No T-cell commitment
• Allows B-cell commitment
• Induces T-cell commitment
• Blocks B-cell commitment
Nucleus Stromal cell
Lymphocyte progenitor
Jagged/Delta-like
CSL CSL
CoR CoA
Presenilin g-Secretase
CoR
(ICN)
Salivary gland aggregate
GFP-Ad FoxN1-Ad
Tissue specific changes
• Expression of transcription factors and other genes are easily modified
• Gene expression modification is tissue type restricted
• Effects on the whole tissue can be studied at the level of morphology, cellular interactions and
signaling
Drug testing
• Toxicity testing
• Efficacy testing
Hepatotoxicity testing
• Purified primary human hepatocytes in 2D
• Complex 3D liver micro-tissues for toxicity
• Toxicity testing (acute and chronic)
• Viability assays
• Bile production
• Molecular marker tests (albumin etc)
Lung model for drug testing
• Complex cellular composition
• Close to physiological drug transporter expression
• Easy handling
• Suitability for HTS